Skip to main content

Lifevantage Corp

LFVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000849146

In the last 90 days, Lifevantage Corp insiders filed 1 open-market purchase and 2 sales; 88 institutions reported holding it in 13F filings for Q2 2026, worth $36.9M in total; no superinvestor holds it.

Currency
USD
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Nov 10, 2026, 1:12 AM ET

Revenue flow, FY2026

Where the revenue went in FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.

Income statement

Each column is one fiscal year, newest first.

Income statement of Lifevantage Corp, annual
Line itemFY2026FY2025FY2024FY2023FY2022
Period endJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022
Filing10-K10-K10-K10-K10-K
ReportedAug 27, 2026Sep 4, 2025Aug 28, 2024Aug 28, 2023Aug 23, 2022
Revenue$182.6M$228.5M$200.2M$213.4M$206.4M
Cost of revenue$41.0M$44.9M$41.4M$43.4M$38.1M
Gross profit$141.6M$183.7M$158.7M$170.0M$168.3M
Operating expenses$135.5M$171.5M$154.4M$165.8M$160.7M
Research and development$1.00M$1.40M$700.0K$600.0K$700.0K
Selling, general and administrative$58.4M$69.2M$68.5M$71.1M$63.4M
Operating income$6.10M$12.2M$4.33M$4.26M$7.58M
Interest expense––-$430.0K-$198.0K$10.0K
Income tax$994.0K$2.44M$1.41M$1.46M$1.57M
Net income$5.07M$9.80M$2.94M$2.54M$3.12M
EPS, basic$0.40$0.80$0.24$0.20$0.24
EPS, diluted$0.40$0.75$0.23$0.20$0.24
Weighted shares, basic12.5M12.3M12.5M12.6M12.9M
Weighted shares, diluted12.7M13.0M13.0M12.6M13.1M
Margins and growth
Gross margin77.6%80.4%79.3%79.7%81.5%
Operating margin3.3%5.3%2.2%2.0%3.7%
Net margin2.8%4.3%1.5%1.2%1.5%
Revenue growth, year over year−20.1%+14.2%−6.2%+3.4%−6.3%
Net income growth, year over year−48.3%+233.8%+15.6%−18.6%−75.8%

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of Lifevantage Corp, annual
Line itemFY2026FY2025FY2024FY2023FY2022
Period endJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022
Filing10-K10-K10-K10-K10-K
ReportedAug 27, 2026Sep 4, 2025Aug 28, 2024Aug 28, 2023Aug 23, 2022
Cash and equivalents–$20.2M$16.9M$21.6M$20.2M
Accounts receivable$2.99M$3.29M$2.95M$1.61M$3.34M
Inventory$16.2M$20.7M$15.1M$16.1M$16.5M
Total current assets$38.3M$50.9M$37.6M$44.3M$47.0M
Property, plant and equipment$7.31M$6.21M$7.81M$9.09M$9.50M
Goodwill$465.0K––––
Intangible assets$3.06M$245.0K$323.0K$455.0K$587.0K
Total assets$62.1M$72.0M$60.3M$66.1M$70.7M
Accounts payable$5.16M$4.60M$5.85M$3.50M$7.46M
Total current liabilities$20.2M$27.2M$22.3M$19.6M$25.7M
Total liabilities$28.5M$37.3M$34.3M$31.5M$39.2M
Shareholders' equity$33.6M$34.6M$26.0M$34.6M$31.5M

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of Lifevantage Corp, annual
Line itemFY2026FY2025FY2024FY2023FY2022
Period endJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022
Filing10-K10-K10-K10-K10-K
ReportedAug 27, 2026Sep 4, 2025Aug 28, 2024Aug 28, 2023Aug 23, 2022
Operating cash flow$10.2M$11.9M$12.2M$6.83M$7.96M
Capital expenditures$3.57M$1.37M$2.25M$3.07M$1.53M
Free cash flow$6.67M$10.5M$9.95M$3.76M$6.43M
Depreciation and amortization$2.77M$3.16M$3.58M$3.58M$3.26M
Stock-based compensation$2.35M$5.70M$3.28M$3.19M$1.77M
Dividends paid$2.34M$2.07M$6.94M$1.59M$378.0K
Share buybacks$2.04M$3.15M$6.43M$822.0K$8.83M
Investing cash flow-$7.31M-$1.37M-$2.25M-$3.06M-$1.53M
Financing cash flow-$7.78M-$7.60M-$14.4M-$2.36M-$8.95M
Net change in cash-$5.28M$3.31M-$4.72M$1.42M-$2.98M
Ratio
Stock-based compensation, % of revenue1.3%2.5%1.6%1.5%0.9%

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Shares outstanding for Lifevantage Corp by cover date
Cover dateShares outstandingChange in a yearFiling
Nov 6, 202612.7M−0.1%SEC
Aug 26, 202612.5M−1.3%SEC
May 4, 202612.6M+0.2%SEC
Feb 3, 202612.8M+1.9%SEC
Nov 3, 202512.7M+1.4%SEC
Sep 3, 202512.7M+1.7%SEC
May 5, 202512.6M−0.9%SEC
Feb 4, 202512.6M−2.5%SEC

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.